NASDAQ: LTRN
Lantern Pharma Inc Stock Ownership - Who owns Lantern Pharma?

Insider buying vs selling

Have Lantern Pharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Aaron Gl Fletcher10% Owner2025-06-137,206$3.09
$22.27kSell
Leslie W. Kreis10% Owner2025-06-134,354$3.09
$13.45kSell
Leslie W. Kreis10% Owner2025-06-1312,319$3.09
$38.07kSell
Leslie W. Kreis10% Owner2025-06-131,903$3.09
$5.88kSell
Leslie W. Kreis10% Owner2025-06-1314,218$3.09
$43.93kSell
Leslie W. Kreis10% Owner2025-06-137,206$3.09
$22.27kSell
Aaron Gl Fletcher10% Owner2025-06-134,354$3.09
$13.45kSell
Aaron Gl Fletcher10% Owner2025-06-1314,218$3.09
$43.93kSell
Aaron Gl Fletcher10% Owner2025-06-131,903$3.09
$5.88kSell
Aaron Gl Fletcher10% Owner2025-06-1312,319$3.09
$38.07kSell

1 of 7

LTRN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when LTRN insiders and whales buy or sell their stock.

LTRN Shareholders

What type of owners hold Lantern Pharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Leslie W. Kreis27.40%2,958,970$12.13MInsider
Aaron Gl Fletcher9.96%1,075,952$4.41MInsider
Bios Capital Management LP9.96%1,075,952$4.41MInstitution
Biological Mimetics Inc9.67%1,044,000$4.28MInsider
David S. Silberstein9.67%1,044,000$4.28MInsider
Arunkumar Asaithambi4.09%441,960$1.81MInsider
Vanguard Group Inc3.37%363,720$1.49MInstitution
CM Management LLC1.85%200,000$820.00kInstitution
Green Park Golf Ventures II LLC1.22%131,697$539.96kInsider
Geode Capital Management LLC0.85%91,891$376.75kInstitution

1 of 3

LTRN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
LTRN20.75%62.01%Net Selling
BTAI0.31%99.69%Net Selling
GRCE27.60%50.93%
CURX0.00%8.87%
IPSC26.19%47.24%Net SellingNet Selling

Lantern Pharma Stock Ownership FAQ

Who owns Lantern Pharma?

Lantern Pharma (NASDAQ: LTRN) is owned by 20.75% institutional shareholders, 62.01% Lantern Pharma insiders, and 17.24% retail investors. Leslie W. Kreis is the largest individual Lantern Pharma shareholder, owning 2.96M shares representing 27.40% of the company. Leslie W. Kreis's Lantern Pharma shares are currently valued at $11.57M.

If you're new to stock investing, here's how to buy Lantern Pharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.